126 related articles for article (PubMed ID: 28498250)
21. The prognostic role of peritoneal cytology in stage IA endometrial endometrioid carcinomas.
Wang L; Li L; Wu M; Lang J
Curr Probl Cancer; 2020 Apr; 44(2):100514. PubMed ID: 31753315
[TBL] [Abstract][Full Text] [Related]
22. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
23. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.
Chi DS; Barakat RR; Palayekar MJ; Levine DA; Sonoda Y; Alektiar K; Brown CL; Abu-Rustum NR
Int J Gynecol Cancer; 2008; 18(2):269-73. PubMed ID: 18334008
[TBL] [Abstract][Full Text] [Related]
24. The evaluation of reliability and contribution of frozen section pathology to staging endometrioid adenocarcinomas.
Karabagli P; Ugras S; Yilmaz BS; Celik C
Arch Gynecol Obstet; 2015 Aug; 292(2):391-7. PubMed ID: 25608758
[TBL] [Abstract][Full Text] [Related]
25. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
[TBL] [Abstract][Full Text] [Related]
26. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
[TBL] [Abstract][Full Text] [Related]
27. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
Ayhan A; Taskiran C; Celik C; Yuce K
Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
[TBL] [Abstract][Full Text] [Related]
28. Survival and disease relapse in surgical stage I endometrioid adenocarcinoma of the uterus after adjuvant vaginal vault brachytherapy.
Kumar VJ; Nin CY; Kuei LY; Tan KH; Yeo R; Lam PY
Int J Gynecol Cancer; 2010 May; 20(4):564-9. PubMed ID: 20686374
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer.
Scott SA; van der Zanden C; Cai E; McGahan CE; Kwon JS
Gynecol Oncol; 2017 May; 145(2):262-268. PubMed ID: 28359690
[TBL] [Abstract][Full Text] [Related]
30. Mucinous differentiation does not impact stage or risk of recurrence among patients with grade 1, endometrioid type, endometrial carcinoma.
Worley MJ; Davis M; Berhie SH; Muto MG; Feltmate CM; Berkowitz RS; Horowitz NS; Campos SM
Gynecol Oncol; 2014 Oct; 135(1):54-7. PubMed ID: 25088333
[TBL] [Abstract][Full Text] [Related]
31. The nature of early-stage endometrial cancer recurrence-A national cohort study.
Jeppesen MM; Jensen PT; Gilså Hansen D; Iachina M; Mogensen O
Eur J Cancer; 2016 Dec; 69():51-60. PubMed ID: 27816832
[TBL] [Abstract][Full Text] [Related]
32. Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli M; Turan V; Gungorduk K; Hasdemir P; Tosun G; Dogan A; Ozdemir A; Adiyeke M; Sanci M
Aust N Z J Obstet Gynaecol; 2015 Feb; 55(1):81-6. PubMed ID: 25688821
[TBL] [Abstract][Full Text] [Related]
33. Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance.
Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H; Yamasaki F
Gynecol Oncol; 1999 Mar; 72(3):273-7. PubMed ID: 10053095
[TBL] [Abstract][Full Text] [Related]
34. High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy.
Sonoda Y; Zerbe M; Smith A; Lin O; Barakat RR; Hoskins WJ
Gynecol Oncol; 2001 Mar; 80(3):378-82. PubMed ID: 11263935
[TBL] [Abstract][Full Text] [Related]
35. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance and treatment implications of positive peritoneal cytology in endometrial adenocarcinoma: Unraveling a mystery.
Wethington SL; Barrena Medel NI; Wright JD; Herzog TJ
Gynecol Oncol; 2009 Oct; 115(1):18-25. PubMed ID: 19632708
[TBL] [Abstract][Full Text] [Related]
37. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
38. Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer.
Dunn EF; Geye H; Platta CS; Gondi V; Rose S; Bradley KA; Anderson BM
Gynecol Oncol; 2014 Jun; 133(3):494-8. PubMed ID: 24657301
[TBL] [Abstract][Full Text] [Related]
39. Effects of uterine manipulation on surgical outcomes in laparoscopic management of endometrial cancer: a prospective randomized clinical trial.
Lee M; Kim YT; Kim SW; Kim S; Kim JH; Nam EJ
Int J Gynecol Cancer; 2013 Feb; 23(2):372-9. PubMed ID: 23266650
[TBL] [Abstract][Full Text] [Related]
40. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.
Schwab KV; O'Malley DM; Fowler JM; Copeland LJ; Cohn DE
Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]